Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,850 | 1,974 | 1,844 | 2,262 | 3,487 |
| Operating Income | -1,850 | -1,974 | -1,844 | -2,262 | -3,487 |
| Other Income | 77 | 101 | 102 | 205 | 164 |
| Pre-tax Income | -1,773 | -1,873 | -1,742 | -2,057 | -3,323 |
| Net Income Continuous | -1,773 | -1,873 | -1,742 | -2,057 | -3,323 |
| Net Income | $-1,773 | $-1,873 | $-1,742 | $-2,057 | $-3,323 |
| EPS Basic Total Ops | -0.24 | -0.48 | -0.08 | -0.32 | -0.56 |
| EPS Basic Continuous Ops | -0.22 | -0.40 | -0.07 | -0.36 | -0.58 |
| EPS Diluted Total Ops | -0.24 | -0.48 | -0.08 | -0.32 | -0.56 |
| EPS Diluted Continuous Ops | -0.22 | -0.40 | -0.07 | -0.36 | -0.58 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.24 | -1.40 | -0.36 | -0.56 |
| EBITDA(a) | $-1,850 | $-1,974 | $-1,844 | $-2,262 | $-3,487 |